medigraphic.com
Instituto Nacional de Salud Pública

2011, Number 6

<< Back Next >>

salud publica mex 2011; 53 (6)

Trends and social indicators of both mortality breast cancer and cervical cancer in Antioquia, Colombia, 2000-2007

Baena A, Almonte M, Valencia ML, Martínez S, Quintero K, Sánchez GI

Language: Spanish
References: 26
Page: 486-492
PDF size: 160.05 Kb.


ABSTRACT

Objective. To estimate the mortality age-standardized rates (ASR) for breast and cervical cancer from 2000-2007 and explore social indicators that explain the variability of rates in Antioquia. Material and Methods. The ASR was estimated by the direct method and linear regression was used to relate social indicators with rates by subregion. Results. Breast and cervical cancer mortality ASRs in Antioquia were 11.3 and 9.1 per 100 000 woman-years respectively. In Medellin, the breast cancer mortality ASR was 12.5, 1.8 times the rate of cervical cancer. A decrease of cervical cancer ASR between 2000 and 2007 was observed in Medellin (p-value=0.03) but not in the rest of Antioquia. Cervical cancer mortality ASR was related to the percentage of poverty (p-value=0.0003). Conclusions. Mortality due to these neoplasms has remained constant in Antioquia. The wide variation in mortality from cervical cancer between regions seems to be associated with poverty.


REFERENCES

  1. Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM. Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 2010; 127(12):2893-2917.

  2. Herrero R, Ferreccio C, Salmeron J, Almonte M, Sanchez GI, Lazcano- Ponce E et al. New approaches to cervical cancer screening in Latin America and the Caribbean. Vaccine 2008;26 (11):L49-L58.

  3. Autier P, Boniol M, La Vecchia C, Vatten L, Gavin A, Hery C, et al. Disparities in breast cancer mortality trends between 30 European countries: retrospective trend analysis of WHO mortality database. BMJ 2010;341:c3620.

  4. Bosetti C, Malvezzi M, Chatenoud L, Negri E, Levi F, La Vecchia C. Trends in cancer mortality in the Americas, 1970-2000. Ann Oncol 2005;16:489-451.

  5. Levi F, Lucchini F, Negri E, La Vecchia C. Trends in mortality from major cancers in the European Union, including acceding countries, in 2004. Cancer 2004;101:2843-2850.

  6. Instituto Nacional de Cancerología. Empresa Social del Estado. Incidencia estimada y mortalidad por cáncer en Colombia 2002-2006. [Consultado agosto 29 de 2011]Disponible en: http://www.cancer.gov.co/contenido/contenido.aspx?catID=437&conID=758&pagID=1350

  7. Pineros M, Pardo C, Gamboa O, Hernández G. Atlas de Mortalidad por Cáncer en Colombia. En: Instituto Nacional de Cancerología IGAC. Bogotá, Colombia: Imprenta Nacional, 2010.

  8. Pineros M, Ferlay J, Murillo R. Cancer incidence estimates at the national and district levels in Colombia. Salud Publica Mex 2006;48:455-465.

  9. Pineros M, Hernandez G, Bray F. Increasing mortality rates of common malignancies in Colombia: an emerging problem. Cancer 2004;101: 2285-2292.

  10. Departamento Administrativo Nacional de Estadística (DANE). Proyecciones de población. [Consultado 2010 febrero]. Disponible en: http://www.dane.gov

  11. Gobernación de Antioquia. Departamento Administrativo de Planeación de Antioquia. Anuario estadístico de Antioquia 2006. [Consultado 2010 marzo 21] Disponible en: http://www.antioquia.gov.co/antioquia-v1/organismos/planeacion/anuario2006/historia/indice-1.htm

  12. Republica de Colombia. Departamento Administrativo Nacional de Estadística DANE. Encuesta de calidad de vida. [Consultado 2010 febrero 15]. Disponible en: http://www.dane.gov.co/index.php?option=com_content&task=category§ionid=35&id=32&Itemid=144

  13. República de Colombia. Departamento Nacional de Planeación. Sistema de Identificación de Potenciales Beneficiarios de Programas Sociales SISBEN. [consultado 2010 abril 12]. Disponible en: http://www.sisben.gov.co

  14. Woodward M. Epidemiology: Study Design and Data Analysis. USA: Chapman and Hall CRC, 2004.

  15. Omar B, Boschi-Pinto C, Lopez A, Murray L, Lozano R, Mie I. Age standardization of rates: A new WHO standard. GPE Discussion Paper No 31. Geneva: World Health Organization, 2001. [Consultado 2010 marzo 15] Disponible en: https://www.who.int/healthinfo/paper31.pdf

  16. República de Colombia. Ministerio de Protección Social. Encuesta Nacional de Demografía y Salud. Salud Sexual y Reproductiva en Colombia ENDS 2010. [Consultado 2010 junio 10]. Disponible en: http://www.profamilia.org.co/encuestas/Profamilia/Profamilia/

  17. Pineros M, Cendales R, Murillo R, Wiesner C, Tovar S. Pap test coverage and related factors in Colombia, 2005. Rev Salud Publica (Bogotá) 2007;9:327-341.

  18. Garcés-Palacio IC, Russell - Kirby MA, McClure LA, Mulvihill B, Scarinci IC. Contribution of health care coverage in cervical cancer screening follow-Up. Int J Gynecol Cancer 2010;20:1232-1239.

  19. Charry LC, Carrasquilla G, Roca S. Equity regarding early breast cancer screening according to health insurance status in Colombia. Rev Salud Publica (Bogota) 2008;10:571-582.

  20. Velasquez-D, Charry LC, Carrasquilla G, Roca-Garavito S. Equity in access to treatment for breast cancer in Colombia. Salud Publica Mex 2009;51(2):S246-S53.

  21. Bedoya AM, Duarte DF, Baena A, López CJ, Combita AL, Salazar JE et al. Seroprevalencia del papilomavirus humano y factores asociados a infección en mujeres de Pueblorrico, Antioquia. Infectio 2008;12 supl 1:60.

  22. Salazar JE, Gaviria A, Grisales H, Casta´no J, Borrero M, López CJ et al. Prevalencia y factores asociados al riesgo de la infección con el virus del papiloma humano en mujeres de Pueblorrico- Antioquia. Infectio 2008;12 S1:88-89.

  23. Murillo R, Almonte M, Pereira A, Ferrer E, Gamboa OA, Jerónimo J, et al. Cervical cancer screening programs in Latin America and the Caribbean. Vaccine 2008;26:L37-L48.

  24. Wiesner C, Cendales R, Murillo R, Pineros M, Tovar S. Following-up females having an abnormal Pap smear in Colombia. Rev Salud Publica (Bogotá) 2010;12:1-13.

  25. Hernández G, Herrán S, Cantor LF. Análisis de las tendencias de mortalidad por cáncer de mama en Colombia y Bogotá, 1981-2000. Rev Colomb Cancerol 2007;11:32-39.

  26. Lazcano-Ponce E, Palacio-Mejía LS, Allen-Leigh B, Yunes-Díaz E, Alonso P, Schiavon R et al. Decreasing cervical cancer mortality in México: effect of papanicolaou coverage, birthrate, and the importance of diagnostic validity of cytology. Cancer Epidemiol Biomarkers Prev 2008;17:2808-2817.




2020     |     www.medigraphic.com